Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-15-126180
Filing Date
2015-04-10
Accepted
2015-04-10 16:37:30
Documents
3
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d903564d10ka.htm 10-K/A 78135
2 EX-10.56 d903564dex1056.htm EX-10.56 318335
3 EX-10.57 d903564dex1057.htm EX-10.57 180416
  Complete submission text file 0001193125-15-126180.txt   578024
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Pharma plc (Filer) CIK: 0001492426 (see all company filings)

EIN.: 272179987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-35238 | Film No.: 15764813
SIC: 2834 Pharmaceutical Preparations